UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Biological psychiatry (1969), ISSN 0006-3223, 2013, Volume 73, Issue 12, pp. 1133 - 1141
Psychiatry | rapid-acting | treatment mechanisms | Antidepressants | ketamine | review | glutamate | Antidepressants glutamate ketamine rapid-acting review treatment mechanisms | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychology. Psychoanalysis. Psychiatry | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Antidepressive Agents - therapeutic use | Depression - drug therapy | Animals | Humans | Antidepressive Agents - pharmacology | Glutamic Acid - metabolism | Ketamine - therapeutic use | Ketamine - pharmacology | Methyl aspartate | Medical colleges | Ketamine | Aspartate | Glutamate | Health aspects | Psychiatric services | Antidepressants, Tricyclic | Index Medicus | antidepressants
Journal Article
Journal of pharmacy practice, ISSN 0897-1900, 2/2014, Volume 27, Issue 1, pp. 71 - 78
serotonin syndrome | tramadol | drug-drug interactions | antidepressants | serotonergic | Age Factors | Monoamine Oxidase Inhibitors - adverse effects | Humans | Risk Factors | Tramadol - pharmacology | Serotonin Syndrome - prevention & control | Tramadol - adverse effects | Monoamine Oxidase Inhibitors - administration & dosage | Dose-Response Relationship, Drug | Serotonin Syndrome - chemically induced | Drug Interactions | Tramadol - administration & dosage | Antidepressive Agents - administration & dosage | Antidepressive Agents - pharmacology | Antidepressive Agents - adverse effects | Evaluation | Usage | Serotonin syndrome | Antidepressants | Drug interactions | Tramadol | Influence | Risk factors | Index Medicus
Journal Article
Journal of affective disorders, ISSN 0165-0327, 05/2020, Volume 269, p. 198
Journal Article
Addictive behaviors, ISSN 0306-4603, 10/2019, Volume 97, pp. 126 - 126
Journal Article
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 10/2018, Volume 89, Issue 10, pp. A36 - A36
Journal Article
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 12/2017, Volume 88, Issue Suppl 1, pp. A30 - A30
Journal Article
Frontiers in pharmacology, ISSN 1663-9812, 10/2020
Journal Article
Biological psychiatry (1969), ISSN 0006-3223, 05/2017, Volume 81, Issue 10, pp. S74 - S75
Journal Article
Biological psychiatry (1969), ISSN 0006-3223, 05/2017, Volume 81, Issue 10, pp. S260 - S260
Journal Article
2016, First edition., ISBN 0374280673, xxii, 310 pages
Book
Neuroscience and biobehavioral reviews, ISSN 0149-7634, 05/2016, Volume 64, p. 311
Journal Article
Toxicology letters, ISSN 0378-4274, 09/2016, Volume 258, pp. S133 - S133
Journal Article
Neuroscience, ISSN 0306-4522, 12/2015, Volume 311, p. 45
Journal Article
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 08/2020, Volume 91, Issue 8, pp. e2 - e2
Journal Article
Pharmaceutical chemistry journal, ISSN 0091-150X, 03/2020, Volume 53, Issue 12, p. 1106
Journal Article
European journal of medicinal chemistry, ISSN 0223-5234, 01/2021, Volume 209
Journal Article
Journal of psychopharmacology (Oxford), ISSN 0269-8811, 05/2014, Volume 28, Issue 5, pp. 403 - 439
treatment | post-traumatic stress disorder | obsessive-compulsive disorder | serotonin-noradrenaline reuptake inhibitor | RANDOMIZED CONTROLLED-TRIAL | SEROTONIN REUPTAKE INHIBITORS | selective serotonin reuptake inhibitor | cognitive behaviour therapy | RESISTANT PANIC DISORDER | specific phobia | COGNITIVE-BEHAVIORAL THERAPY | antipsychotics | PRIMARY-CARE PATIENTS | QUALITY-OF-LIFE | generalised anxiety disorder | benzodiazepines | separation anxiety disorder | anxiolytics | evidence-based guidelines | anxiety disorders | antidepressants | EVIDENCE-BASED PHARMACOTHERAPY | Anticonvulsants | VENLAFAXINE EXTENDED-RELEASE | social anxiety disorder | pregabalin | PLACEBO-CONTROLLED TRIAL | MAJOR DEPRESSIVE DISORDER | panic disorder | Neurosciences | Clinical Neurology | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Neurosciences & Neurology | Psychiatry | Science & Technology | Anxiety disorders. Neuroses | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psycholeptics: tranquillizer, neuroleptic | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Post-traumatic stress disorder | Obsessive-compulsive disorders | Antidepressive Agents - therapeutic use | Decision Making | Evidence-Based Medicine - methods | Delivery of Health Care - methods | Obsessive-Compulsive Disorder - drug therapy | Stress Disorders, Post-Traumatic - drug therapy | Humans | Psychopharmacology - methods | Anxiety Disorders - drug therapy | Practice guidelines (Medicine) | Anxiety | Research | Drug therapy | Analysis | Intervention | Mental health care | Emotional disorders | Pharmacology | Decision making | Index Medicus | Practice Guideline | Drug Therapy | Epidemiology | PTSD | Panic Disorder | Phobia | Anxiety Disorders | Treatment | Obsessive-Compulsive Disorder | Evidence Based Treatment | Generalized Anxiety Disorder | Diagnosis | Medicin och hälsovetenskap
Journal Article